Frontlight ResearchEarly access
Trial site
Kansai Electric Power Hospital
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes3 trials
- Chronic kidney disease2 trials
- Chronic rhinosinusitis with nasal polyps1 trial
- Obesity1 trial
- Peripheral artery disease1 trial
- Phase
- Phase 37 trials
- Status
- Completed3 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Boehringer Ingelheim2 trials
Running trials
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026